# Bicara Therapeutics (BCAX) — News

BCAX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bcax/news

## Recent headlines

- [Bicara Therapeutics announces inducement grants under Nasdaq listing rule 5635(C)(4)](https://www.ainvest.com/news/bicara-therapeutics-announces-inducement-grants-nasdaq-listing-rule-5635-4-2610) — AInvest Wire, Oct 5, 2026
  Bicara Therapeutics (Nasdaq: BCAX) has announced the issuance of inducement grants in accordance with Nasdaq Listing Rule 5635(C)(4). These grants are part of the company’s ongoing efforts to align with regulatory requirements and support its strategic objectives. The move reflects standard…
- [Bicara Therapeutics - appoints Jenn Larson as CFO effective August 12, 2026](https://www.ainvest.com/news/bicara-therapeutics-appoints-jenn-larson-cfo-effective-august-12-2026-2608) — AInvest Wire, Aug 11, 2026
- [Bicara Therapeutics - appoints Ryan Cohlhepp as president & CEO effective January 2027](https://www.ainvest.com/news/bicara-therapeutics-appoints-ryan-cohlhepp-president-ceo-effective-january-2027-2608) — AInvest Wire, Aug 11, 2026
  Bicara Therapeutics Inc. (Nasdaq: BCAX) has announced that Ryan Cohlhepp, PharmD, will assume the role of President and Chief Executive Officer effective January 2027. Cohlhepp, who currently serves on the company’s team and brings expertise in science and patient care, will succeed Claire…
- [Bicara Therapeutics announces inducement grants under Nasdaq listing Rule 5635(c)(4)](https://www.ainvest.com/news/bicara-therapeutics-announces-inducement-grants-nasdaq-listing-rule-5635-4-2607) — AInvest Wire, Jul 2, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).